Navigation Links
Dr. Sherrell Aston Addresses the Popularity of Dermal Fillers and Possible Long Term Side Effects
Date:1/12/2009

NEW YORK, Jan. 12 /PRNewswire/ -- What to do in a sagging economy? Not necessarily the quick fix that you think, says Dr. Sherrell Aston, one of the country's leading plastic surgeons.

Recently, the U.S. Food and Drug Administration (FDA) gathered a panel of experts to discuss possible safety concerns regarding the use of dermal fillers. Although the injections have been approved to fill in severe wrinkles around the nasolabial fold (the creases running from the nose to the corners of the mouth), the FDA is concerned that their extensive use in other situations may present new safety issues that should be addressed.

According to the FDA, the injections are increasingly being used to augment tissue volume such as the lips, rather than just fill in the nasolabial fold, and the FDA asked panelists if new safety data is needed before such applications can be approved.

Furthermore, as the majority of pre-market approval studies are conducted on fair-skinned subjects, the FDA is concerned increasing use of the cosmetic injections by African American and Latin American skin types may lead to hitherto undocumented side effects such as pigmentation problems. The manufacturers of popular soft tissue filler, Artefill, have recently filed bankruptcy as well.

Dr. Sherrell Aston, leading aesthetic plastic surgeon in Manhattan, states "Fillers are being overdone. People are being told they need volume replacement when they haven't lost volume. Some people are having fillers to the point of looking odd with faces that are just too big for their body, and contour problems like lumps and bumps becoming noticeable. Does it seem logical that one can repetitively put foreign substances in the delicate facial tissues and not have problems later?"

Dr. Aston continues, "Despite the abundance of these less invasive procedures for facial rejuvenation, facelifts are increasingly popular choice for consumers as many patients who have opted for nonsurgical procedures alone ended up disappointed when outcomes didn't meet their expectations." Patients routinely spend thousands of dollars on less invasive treatments when a surgical procedure could have brought more satisfying long-term results faster and more cost-effectively.

Recipients of facelifts today require 10 days to two weeks to attend a social function; and three weeks to return to full athletic activity. Short-incision facelifts look very good in seven to 10 days. Today's facelift procedures are technically sophisticated and highly individualized for the particular patient depending upon their anatomy and needs. Repositioning the underlying foundation rather than just the skin is the key to a refreshed and more youthful but not-operated-on look. Most patients in their 40s and early 50s do not need volume added in their face, but rather volume repositioning of the sagging tissues. Some individuals may lose facial fat as they get older and will benefit from fat grafting or a filler substance very judiciously-placed.

For additional information, please visit Dr. Aston's website at www.draston.com.


'/>"/>
SOURCE Dr. Sherrell Aston
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Phillipsburg Easton Honda to Host Miller-Keystone Blood Drive
2. Orbel Opens New Electroplating and Photo Chemical Milling Facility in Easton, PA
3. TransUnion Revenue Manager Addresses Red Flags Regulations
4. Capella University Launches PhD in Counselor Education and Supervision : The new degree program, one of few available online, addresses growing need for counseling faculty and supervisors
5. Pilot Program Successfully Addresses Mental Health Issues in Pennsylvanias Children
6. Missouri Firms New Ventilator Design Addresses Serious Homeland Security Issue
7. AVMA Addresses Livestock Health Issues Before U.S. Congress
8. New paper addresses myths, realities of government retiree health care crisis
9. Harris Corporations Jim Traficant Addresses Florida Agency for Health Care Administration
10. Tubbs Jones Addresses Health Disparities Issue During Hearing
11. Medlines Pressure Ulcer Prevention Program Addresses New CMS Deadline of October 1, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... June 23, 2017 , ... Everybody has their own personal preference ... to read it, and some people don't like it at all. FindaTopDoc took a ... found: , Erotic literature can give readers a taste of their deepest, darkest fantasies ...
(Date:6/23/2017)... ... June 23, 2017 , ... The Aesthetic Channel has recently ... Talei has come up with a proprietary technique that he calls the AuraLyft ... have dropped. For all ages, patients can expect to look refreshed, rejuvenated, and revitalized. ...
(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... ... Breast Cancer Conference from Sept. 18 to 20. , The two-day conference is ... subtype with the goal of improving patients’ lives and eliminating racial breast cancer-related ...
(Date:6/23/2017)... ... June 23, 2017 , ... MD Now Urgent Care ... MD Now’s 28th facility overall and marks the urgent care center's eighth location in ... North of The Falls shopping mall. The new clinic offers a wide array of ...
(Date:6/23/2017)... ... June 23, 2017 , ... ... Insurance offerings. With the Federal Emergency Management Agency’s (FEMA) recent update of flood ... States. In 2012, the Biggert-Waters Act was enacted to reflect the actual risk ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... , June 6, 2017  Diplomat Specialty Infusion Group, a brand ... environment to its Iowa location. ... now features an ISO 7 cleanroom—the standard needed to ... with a low level of pollutants. ... nutrition consumers and better serve our Iowa ...
(Date:6/2/2017)... June 2, 2017  NxStage Medical, Inc. (Nasdaq:  NXTM), a leading ... announced new findings demonstrating positive biochemical outcomes related to ... One™. The data will be presented at the ERA-EDTA ... Madrid, Spain . The research ... Dialysis Network in Europe ...
(Date:5/30/2017)... , May 30, 2017 Therapix Biosciences Ltd. ... specializing in the development of cannabinoid-based drugs, today ... company overview at three upcoming scientific and investor ... LD Micro Invitational: ... Date:                     ...
Breaking Medicine Technology: